T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.52B |
| 2 |
Boeing
BA
|
+$1.89B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.43B |
| 4 |
Amphenol
APH
|
+$1.1B |
| 5 |
CME Group
CME
|
+$911M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.87B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.1B |
| 3 |
UnitedHealth
UNH
|
+$1.83B |
| 4 |
Uber
UBER
|
+$1.56B |
| 5 |
Adobe
ADBE
|
+$1.29B |
Sector Composition
| 1 | Technology | 33.26% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.14% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Aura Biosciences
AURA
$384M
| $4.58M | ﹤0.01% |
556,941
+40,815
| +8% | +$336K |
|
1302
Ryman Hospitality Properties
RHP
$6.31B
| $4.58M | ﹤0.01% |
43,873
+3,993
| +10% | +$417K |
|
1303
Prosperity Bancshares
PB
$6.44B
| $4.53M | ﹤0.01% |
60,113
+4,339
| +8% | +$327K |
|
|
JBTM
1304
JBT Marel Corporation
JBTM
$7.14B
| $4.51M | ﹤0.01% |
35,472
+8,242
| +30% | +$1.05M |
|
1305
Dolby
DLB
$6.85B
| $4.51M | ﹤0.01% |
57,694
-137,921
| -71% | -$10.8M |
|
1306
Kemper
KMPR
$3.35B
| $4.5M | ﹤0.01% |
67,686
-42,667
| -39% | -$2.84M |
|
1307
AGNC Investment
AGNC
$10.7B
| $4.48M | ﹤0.01% |
486,010
+66,289
| +16% | +$611K |
|
1308
KB Home
KBH
$4.48B
| $4.45M | ﹤0.01% |
67,758
+16,576
| +32% | +$1.09M |
|
1309
Cadence Bank
CADE
$7.02B
| $4.44M | ﹤0.01% |
128,885
+12,427
| +11% | +$428K |
|
1310
First American
FAF
$6.87B
| $4.44M | ﹤0.01% |
71,036
-6,691
| -9% | -$418K |
|
1311
Lyell Immunopharma
LYEL
$246M
| $4.42M | ﹤0.01% |
345,537
-22,077
| -6% | -$283K |
|
1312
SPDR Blackstone Senior Loan ETF
SRLN
$6.96B
| $4.37M | ﹤0.01% |
104,700
| – | – |
|
1313
Chord Energy
CHRD
$5.96B
| $4.34M | ﹤0.01% |
37,071
+3,359
| +10% | +$393K |
|
1314
Alarm.com
ALRM
$2.78B
| $4.33M | ﹤0.01% |
71,133
+3,530
| +5% | +$215K |
|
1315
Lumen
LUMN
$6.21B
| $4.3M | ﹤0.01% |
809,269
+65,168
| +9% | +$346K |
|
1316
Idacorp
IDA
$6.77B
| $4.29M | ﹤0.01% |
39,230
-16,488
| -30% | -$1.8M |
|
1317
Cal-Maine
CALM
$5.37B
| $4.28M | ﹤0.01% |
41,592
+10,972
| +36% | +$1.13M |
|
1318
Snap
SNAP
$12.4B
| $4.28M | ﹤0.01% |
397,526
-61,164
| -13% | -$659K |
|
1319
Argan
AGX
$3.18B
| $4.26M | ﹤0.01% |
31,078
+4,341
| +16% | +$595K |
|
1320
UroGen Pharma
URGN
$869M
| $4.2M | ﹤0.01% |
393,984
+381,145
| +2,969% | +$4.06M |
|
|
ZBIO
1321
Zenas BioPharma, Inc. Common Stock
ZBIO
$852M
| $4.19M | ﹤0.01% |
511,220
+24,366
| +5% | +$200K |
|
1322
Gentex
GNTX
$6.25B
| $4.16M | ﹤0.01% |
144,713
+6,984
| +5% | +$201K |
|
1323
MGIC Investment
MTG
$6.55B
| $4.15M | ﹤0.01% |
175,151
+13,089
| +8% | +$310K |
|
1324
TFI International
TFII
$7.77B
| $4.15M | ﹤0.01% |
30,736
+418
| +1% | +$56.5K |
|
1325
James River Group
JRVR
$244M
| $4.14M | ﹤0.01% |
850,526
+428,636
| +102% | +$2.09M |
|